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Abstract
Objectives: To evaluate the accuracy of a new COVID-19 prognostic score based on 
lung ultrasound (LUS) and previously validated variables in predicting critical illness.
Methods: We conducted a single-center retrospective cohort development and in-
ternal validation study of the COVID-19 Worsening Score (COWS), based on a com-
bination of the previously validated COVID-GRAM score (GRAM) variables and LUS. 
Adult COVID-19 patients admitted to the emergency department (ED) were enrolled. 
Ten variables previously identified by GRAM, days from symptom onset, LUS find-
ings, and peripheral oxygen saturation/fraction of inspired oxygen (P/F) ratio were 
analyzed. LUS score as a single predictor was assessed. We evaluated GRAM model's 
performance, the impact of adding LUS, and then developed a new model based on 
the most predictive variables.
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1  | INTRODUC TION
By the beginning of 2020, a novel disease called COVID-19 was rec-
ognized and eventually defined as a pandemic by the WHO.1 The dis-
ease-causing virus, known as SARS-CoV-2, with its high tropism for 
the lower respiratory tract, can produce an infection with a broad 
spectrum of symptoms ranging from asymptomatic to severe acute 
respiratory failure, often requiring intensive care unit (ICU) admission.2
Since the beginning of the pandemic, many healthcare facili-
ties reorganized entire departments where multidisciplinary teams 
collaborated to provide care for COVID-19 patients. Massive ef-
fort from the worldwide medical community has been put forth to 
better understand the pathophysiology of this disease, in order to 
provide appropriate care, optimize hospital resources, and increase 
efficiency of workflow. In this context, the availability of an easy-
to-use standardized scoring system would have been of great help 
in supporting clinicians with different backgrounds to better iden-
tify patients at higher risk of developing a critical illness. Aiming to 
provide means for a better resource allocation, several prediction 
models have been developed over the last few months. Vital param-
eters, comorbidities, and blood test results have been combined to 
predict disease severity and outcomes for hospitalized COVID-19 
patients.3-11
Among them, Liang et al developed the COVID-GRAM score, 
which showed success in the early prediction of critical illness de-
velopment, defined as admission to the ICU, need for invasive me-
chanical ventilation (IMV), or death.4 However, the GRAM score 
requires ten independent variables, including laboratory results 
and chest X-ray and requires online calculations to risk stratify pa-
tients. Despite its accuracy, its use could be time-consuming as not 
all required parameters are readily available in all settings. In fact, 
during the first pandemic peak, healthcare facilities experienced an 
unexpected patient influx to the emergency department (ED) and 
medical wards with an average of 60 to 80 COVID-19 patients per 
hour. Based on this very early Italian experience, such patient in-
fluxes made serial radiological imaging unfeasible. For this reason, a 
less burdensome and rapid prognostic score may be of considerable 
benefit.
Several of the above-mentioned prognostic scores integrated 
radiological data (ie, chest X-ray or CT scan), but no study has yet in-
vestigated the performance of lung ultrasound (LUS) as a prognostic 
tool in COVID-19 patients. LUS is available at the patient's bedside, 
and its reliability and speed as a tool to evaluate acute respiratory 
disorders in real-time have been well established.12,13 Moreover, 
COVID-19 has a distinctive distribution pattern involving mainly the 
peripheral and lower regions of the lungs,14 and presumably this is 
why LUS demonstrated superior sensitivity to CT scan for pleural 
and subpleural abnormalities.15 According to the available literature 
and contingent need, LUS may play a central role in this pandemic 
where the risk of healthcare workers’ exposure and patients’ over-
flow has been a primary concern.
We hypothesized that a new prognostic score, integrating previ-
ously validated variables and LUS findings instead of chest radiogra-
phy, could work as well as the GRAM score for the early identification 
of COVID-19 patients developing critical illness. Hence, we firstly 
tested the GRAM score on our cohort and then developed and inter-
nally validated the new COVID-19 Worsening Score (COWS).
2  | METHODS
2.1 | Study design
We conducted a single-center retrospective cohort validation study 
of the GRAM score and subsequently developed and internally vali-
dated a new prognostic score.
Results: Among 274 COVID-19 patients enrolled, 174 developed critical illness. The 
GRAM score identified 51 patients at high risk of developing critical illness and 132 at 
low risk. LUS score over 15 (range 0 to 36) was associated with a higher risk ratio of 
critical illness (RR, 2.05; 95% confidence interval [CI], 1.52-2.77; area under the curve 
[AUC], 0.63; 95% CI 0.676-0.634). The newly developed COVID-19 Worsening Score 
relies on five variables to classify high- and low-risk patients with an overall accuracy 
of 80% and negative predictive value of 93% (95% CI, 87%-98%). Patients scoring 
more than 0.183 on COWS showed a RR of developing critical illness of 8.07 (95% 
CI, 4.97-11.1).
Conclusions: COWS accurately identify patients who are unlikely to need intensive 
care unit (ICU) admission, preserving resources for the remaining high-risk patients.
K E Y W O R D S
COVID-19, critical care, intensive care, lung sonography, lung ultrasound, prognostic score
     |  209BOERO Et al
The study adhere to the Transparent Reporting of a multivariable 
prediction model for Individual Prognosis Or Diagnosis (TRIPOD) 
guidelines.16
2.2 | Study population and Setting
The study was conducted in an Italian tertiary Hospital in Turin (San 
Giovanni Bosco Hospital). All adult patients with a confirmed diag-
nosis of SARS-CoV-2 infection admitted to the ED and thereafter to 
the medical wards during the epidemic peak between February 26 
and May 17 were enrolled. Patients with hospital-acquired COVID-
19, previous pneumonectomy, or lobar pneumonia on presentation 
were excluded. SARS-CoV-2 infection disease was confirmed by 
real-time polymerase chain reaction (RT-PCR) performed either on 
nasal swab or on pharyngeal swab. The patients' notes and imaging 
results were retrieved from electronic medical records, collected in 
a dedicated COVID-19 database, and retrospectively analyzed. The 
City of Turin Ethical Committee approved the study on June 3, 2020 
(protocol #82995). The hospital review board waived patients' con-
sent due to the retrospective nature of the study and anonymous 
data handling and analysis.
2.3 | Patients characteristics and clinical outcomes
Patient demographic characteristics, comorbidities, presenting 
symptoms and date of their onset, clinical signs, laboratory test re-
sults, and sonographic and radiological findings (chest X-ray and/or 
CT) were collected within 48 hours of ED admission. The arterial 
oxygen partial pressure to fractional-inspired oxygen (P/F) ratio was 
also recorded.
The adverse outcome referred to as critical illness in the results 
section was defined by the occurrence of at least one of the fol-
lowing three events: admission to ICU, need for invasive mechanical 
ventilation (IMV), or death17,18 due to COVID-19 within a follow-up 
of 30 days postadmission. Supplementary oxygen support or nonin-
vasive ventilation (NIV) was considered favorable outcomes. Need 
for IMV and ICU admission was decided based on standard of care 
criteria.19
2.4 | Variables selection
Among the patients’ collected data, we selected the ten vari-
ables previously identified in the GRAM score. We chose these 
ten variables due to their ability to predict the severity of respira-
tory failure and progression to critical illness.20 Moreover, P/F 
ratio on admission and number of days from symptoms onset were 
included in the analysis. Missing data were further searched in 
available materials such as handover and notes. In patients that 
underwent a CT scan, we considered the following findings: the 
number of pulmonary lobes involved the presence of emphysema 
and the percentage of well-aerated lung. These radiological fea-
tures were predictors of ICU admission or death in COVID-19 in a 
previous study.11
CT scans (obtained by 64 Slice Discovery HD 750 CT Scanner, 
General Electric) and chest X-rays were analyzed by a radiologist 
with more than ten years of chest imaging experience blinded to pa-
tients' outcomes.
The LUS protocol adopted for the study was comprehensive of 
6 scanning areas per hemithorax as previously described.21 Each 
hemithorax was assessed in one upper and one lower area in the 
three regions divided by the parasternal, anterior, and posterior ax-
illary lines, respectively. The image focus was placed at the level of 
the pleural line maintaining the image depth at 8-12 cm.13 An already 
validated aeration score was assigned to each area,22 and the final 
LUS score was calculated as the sum of them.
LUS evaluation was performed by 29 clinicians with more than 
five years of experience in bedside sonographic imaging, and 7 of 
them subsequently calculated the lung aeration score on all included 
patients (EB, MC, GL, MC, AG, GF, SS). When in doubt, a second 
operator (EB) reviewed both imaging and score.
Low- to high-medium frequency (2-9 MHz) curvilinear probes 
and three different ultrasound machines were selected for the study 
(MyLab 5™, MyLab 7™; Esaote, and Sonosite M-Turbo™ Ultrasound 
System, Fujifilm).
2.5 | Statistical analysis
Continuous variables were reported as mean and standard devia-
tion (SD) or median with interquartile range (IQR) as appropriate and 
categorical variables as numbers and percentages.
Evaluation of the LUS score as a predictor of the adverse evo-
lution of COVID-19 infection was assessed by univariate level. 
Restricted cubic splines were modeled to assess the nonlinear effect, 
and significance was tested by the Wald chi-square. Significance 
level was set at 0.05. Finally, the LUS score was dichotomized by 
the ROC curve analysis. Application of the COVID-GRAM model on 
our sample was carried out to evaluate its performance in classifying 
high- and low-risk patients according to the threshold identified by 
the ROC curve analysis. The evaluation of the COVID-GRAM added 
with the LUS score was then performed.
Aiming to develop a novel and easy to use prognostic score, a 
selection strategy based on Bayesian model averaging was adopted. 
The number of comorbidities, LUS score, P/F ratio, dyspnea, and du-
ration of symptoms (days) showed a posterior probability of inclusion 
greater than 30% and was retained in the final logistic regression 
model labeled as COWS. Thirty percent was chosen as the cutoff 
through sensitivity analysis to maximize the bootstrapped predictive 
accuracy of the selected model.
The performance of the model was assessed in terms of Somers 
concordance index Dxy (the closer to 1, the better), Brier score 
(scores closer to zero indicate a better prediction), and calibra-
tion slope. An internal validation to correct measures of predictive 
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performance for optimism (over-fitting) was performed by boot-
strapping 500 samples of the data.
To improve the prediction, a shrinkage bootstrap-based method 
was applied to re-estimate regression coefficients. The overall op-
timism across all models was estimated deriving a shrinkage co-
efficient equal to the average calibration slope from each of the 
bootstrap samples. The shrinkage coefficient was applied to the 
original coefficient to account for over-fitting. Finally, the intercept 
was re-estimated based on the shrunken coefficients to ensure the 
overall calibration was maintained, producing the final model. All 
analyses were carried out using R 4.0.0.23
3  | RESULTS
Between February 26 and May 17 2020, 274 COVID-19 patients 
were admitted to the wards from the ED (Figure 1). Baseline clini-
cal characteristics are summarized in Table 1. One hundred and sev-
enty-four patients had a final adverse outcome (critical illness), while 
100 patients had a favorable outcome (noncritical illness). Complete 
data for the study analysis, including LUS findings, were available in 
143 cases. The mean time between ED admission and outcome was 
5.1 days (SD, 5.4; median 3.8; IQR, 1-7).
3.1 | Performance of GRAM score in this cohort
Necessary data for GRAM score calculation were available in 183 
patients. Using the published threshold (40%) for the GRAM score4 
F I G U R E  1   Diagram of included patients
TA B L E  1   Demographics and clinical characteristics of the patients who did and did not develop critical illness
Characteristic Total (n = 274) No critical illness (n = 174) Critical illness (n = 100) P-value
Age, mean (SD) [range] 67.7 (14.4) [21-96] 64.9 (14.5) [21-96] 72.6 (12.8) [35-89] <.000
Gender, male (%) 189 (69.0) 117 (67.2) 72 (72.0) .412
Days from symptom onset, mean (SD) 
[range]
5.8 (4.4) [0-31] 6.4 (4.8) [0-31] 4.8 (3.5) [0-14] .009
Number of comorbidities (n = 268) (n = 171) (n = 97) <.000
0 71 (24.2) 56 (32.7) 15 (15.5)
1 71 (24.2) 53 (31.0) 18 (18.6)
2 58 (19.8) 31 (18.1) 27 (27.8)
3 38 (13.0) 20 (11.7) 18 (18.6)
4 22 (7.5) 8 (4.7) 14 (14.4)
5+ 8 (2.7) 3 (1.8) 5 (5.1)
Malignancy (%) 20 (7.4) 11 (6.4) 9 (9.3) .387
Dyspnea (%) 139 (51.7) 75 (43.9) 64 (65.3) .001
Hemoptysis (%) 2 (0.74) 1 (0.58) 1 (1.02) .597
Unconsciousness (%) 2 (0.74) — 2 (2.04) .132
Abnormal chest radiography/CT (%) 201 (82.4) 124 (77.0) 77 (92.8) .002
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to discriminate between high- and low-risk patients, we identified 51 
patients at high risk and 132 at low risk of developing critical illness 
(Figure 2). When applied to the 143 patients who were integrated 
in the final analysis, no difference in GRAM score performance was 
found.
3.2 | LUS score as a predictor of the main outcome
LUS images were successfully obtained in 211 patients. LUS aeration 
score ranged from a minimum of 0 to a maximum of 27, with a mean 
of 12.1 (SD, 7.4; median, 12) in favorable outcome patients and a 
mean of 16.2 (SD, 7.3; median, 17) in critically ill patients (P < .001). 
A higher LUS score was associated with a higher risk ratio (RR) of 
developing critical illness (RR, 2.05; 95% CI 1.52-2.77) (Figure 3). A 
value over 15 (out of 0 to 36) on LUS score demonstrated predictive 
discrimination between favorable and adverse outcomes (area under 
the curve [AUC], 0.63; 95% CI 0.676-0.634).
3.3 | Performance of GRAM score powered by LUS
As an intermediate analysis, we investigated whether the com-
bination of the dichotomous LUS score with the COVID-GRAM 
score could increase the performance of GRAM score alone in 
predicting adverse outcome. We named this combined score 
F I G U R E  2   GRAM score derived risk groups (on the left) and outcomes (on the right); gray shadows link classification to outcomes and 
their width is proportional to the number of patients
F I G U R E  3   Probability of developing 
critical illness (Y-axis) according to 
increasing values of LUS score (X-axis)
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GRAM-PLUS (GRAM powered by LUS). This calculation was per-
formed in 143 patients based on the available data. The addition 
of sonographic findings to the GRAM score slightly reduced the 
number of patients of the low-risk category as initially established 
by the GRAM score and raised the RR from 3.0 to 3.18 (Table 2, 
Figure 4).
Of note, when GRAM-PLUS was validated in our cohort of pa-
tients, unconsciousness and hemoptysis were ignored as these signs 
were absent. The optimism-adjusted model accuracy index was 
0.5193 providing an estimated accuracy of 75.97%.
3.4 | Performance of COVID-19 Worsening Score 
(COWS)
By using the Bayesian averaging model, we selected five predictive 
variables with their relative coefficients as follow: LUS score greater 
than 15, the number of comorbidities, days from the symptom onset, 
dyspnea at presentation, and P/F ratio (Table 3).
COWS ranged from 0 to 1, and the optimal accuracy was iden-
tified at a threshold of 0.183. Using this threshold, the same 143 
patients were reclassified in 60 high-risk patients, of whom 35 
(58.3%) developed critical illness, and 83 low-risk patients, of whom 
6 (7.2%) developed critical illness (Figure 5). Sensitivity and specific-
ity for critical illness were 0.85 (95% CI, 0.75-0.96) and 0.75 (95% CI, 
0.67-0.84), respectively. Positive predictive value (PPV) and nega-
tive predictive value (NPV) were 0.58 (95% CI, 0.46-0.71) and 0.93 
(95% CI, 0.87-0.98), respectively. The risk ratio increased to 8.07 
TA B L E  2   Comparative performance of the three scores (GRAM, GRAM-PLUS, and COWS) on 143 patients with available data












GRAM score 22 (56.4) 17 (43.6) 39 19 (18.3) 85 (81.7) 104 3.0 (2.02-4.09) <.001
GRAM-PLUS 24 (54.5) 20 (45.5) 44 17 (17.2) 82 (82.8) 99 3.18 (2.07-4.25) <.001
COWS 35 (58.3) 25 (41.7) 60 6 (7.2) 77 (92.8) 83 8.07 (4.97-11.1) <.001
F I G U R E  4   Distribution curves of the 
patients who developed critically illness 
(red dots) and those who had favorable 
outcomes (green dots). X-axis: linear 
predictor; Y-axis: incremental values of 
GRAM score (upper panel) and GRAM-
PLUS values (lower panel). LUS: lung 
ultrasound
TA B L E  3   Most predictive variables identified and their effect 
with 95% confidence intervals
Variable Effect 95% CI P-value
Number of 
comorbidities
1.688 1.216 — 2.344 .002
LUS score above 15 3.511 1.283 — 9.612 .015
PF ratio 0.218 0.109 — 0.434 <.001
Days from symptom 
onset
0.595 0.340 — 1.041 .069
Dyspnea 0.308 0.097 — 0.976 .045
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F I G U R E  5   Performance of the COWS 
in classifying high- and low-risk patients. 
Red dots indicate patients with adverse 
outcome. Dashed line refers to the COWS 
threshold
F I G U R E  6   Nomogram of COVID-19 Worsening Score and how to use it
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(95% CI, 4.97-11.1) (Table 2). The equation to calculate COWS is 
shown (below) in Formulas 1 and 2. Finally, we created a nomogram 
that can be used to calculate COWS manually (Figure 6).
Risk model formula
Formulas 1 and 2. Linear predictor calculation and 
subsequent COW score calculation. LP = linear pre-
dictor; C = number of comorbidities; PF = PF ratio 
(mmHg); S = days from symptoms onset; L = LUS score; 
D = dyspnea.
3.5 | Potential role of CT scan in reclassifying false-
positive and -negative patients
After visual inspection of the COWS classification in high- and low-
risk patients, we wondered whether second level radiological imag-
ing, such as a thoracic CT scan, might be a viable means to improve 
the prediction of patients' outcome. Among the 143 patients with 
complete data, 46 were misclassified by COWS (ie, they turned out 
to be false-positive or false-negative). CT scan data were available 
only for 59 patients, of whom 55 presented completed data. No 
statistically significant results were found between the 39 patients 
incorrectly classified in the high-risk group compared to the 7 in-
correctly classified in the low-risk group. The number of involved 
lobes was greater in high-risk than in the lower risk group (mean 5 vs 
2.5; P = .43) as well as the percentage of emphysema (46.7% in the 
higher risk vs 0% in the lower risk group; P = .485). Percentage of 
well-aerated lung was also lower in high-risk group (75.0% vs 87.5%; 
P = .229).
4  | DISCUSSION
In this study, we developed and validated a new prognostic bedside 
score for early identification of COVID-19-related critical illness 
and named it COVID-19 Worsening Score (COWS). This new score 
integrated LUS findings and three selected variables of the previ-
ously validated COVID-GRAM score. Since COWS does not require 
laboratory or radiological results, it enables rapid stratification of 
patients upon ED arrival. This aspect is critical when considering the 
large COVID-19 patient influxes seen worldwide, which occasion-
ally necessitated opening of outdoor tent areas and screening of pa-
tients in parking lots.
The overall accuracy of COWS is 80%, which is equal to the 
GRAM score. However, with a negative predictive value of 93%, 
COWS better discriminates low-risk patients than the GRAM score 
and may thus help in reducing inappropriate ICU admissions and op-
timizing hospital resources. Moreover, the ability to anticipate clini-
cal worsening could provide benefits to patients, such as shortening 
the time spent on spontaneous breathing, or on NIV, to prevent pa-
tient self-inflicted lung injury (P-SILI).24,25
COVID-GRAM score and COWS are not the only recently pro-
posed scores. Several other prognostic scores were developed based 
on varying mixes of clinical data, laboratory results, and radiological 
findings. Zhou et al proposed a predictor of disease severity obtained 
from combining three independent variables: the neutrophils to lym-
phocytes ratio (N/L), C-reactive protein (CRP), and D-dimer values. 
This product had better predictive performance than single biomark-
ers as proved by an internal validation study.3 Several radiological 
scoring systems were also implemented to assess the severity of the 
disease and predict patient's outcomes. A chest X-ray (CXR) scoring 
system on 18-point scale, known as Brixia score, was proposed to 
quantify and monitor the severity of lung abnormalities.5 The Brixia 
score when combined with the patient's age and presence of immu-
nosuppression was shown to predict in-hospital mortality.6 In a retro-
spective single-center study evaluating 1,198 ED COVID-19 patients, 
the accuracy of both CXR and computerized CT scan for diagnosis of 
COVID-19 was investigated. Sensitivity and specificity of CXR were 
0.56 and 0.60, whereas for CT scan these were 0.85 and 0.50, re-
spectively.7 Despite its low specificity, CT confirmed the diagnosis of 
COVID-19 in patients with a false-negative RT-PCR as demonstrated 
in Chen et al study. The lower the number of pulmonary consolida-
tions on the CT, the greater the likelihood of a negative RT-PCR, sug-
gesting the central role of CT as screening tool when COVID-19 is 
strongly suspected.8 Association between CT findings and patient 
mortality was also studied.9 Kunhua et al investigated the combina-
tion of CT findings and clinical features in critical versus noncritical 
COVID-19 patients. Results indicated that CT could identify patients 
who needed aggressive treatment and close monitoring.10 Another 
retrospective analysis investigated the link between lung aeration at 
baseline CT with the patient's adverse outcome: The degree of air loss 
and the presence of 4 or more lung lobes affected by COVID-19 pneu-
monia were associated with admission to ICU or death.11
Hence, it may be suggested that CT scanning could be the op-
timal imaging tool in COVID-19, but it carries the burden of radia-
tion exposure, higher cost, and prolonged equipment cleaning time 
compared to LUS.26 Moreover, both CT and LUS are not specific 
for COVID-19 pneumonia.27 Keeping a balance between accuracy 
and availability, LUS is a tool able to identify early signs of pulmo-
nary lesions of COVID-19 pneumonia. Even though LUS cannot de-
termine per se whether patients are infected by SARS-CoV-2, our 
results showed that in established COVID-19 cases, the higher the 
LUS score, the greater was the risk of developing critical illness. We 
identified that a LUS score value higher than 15 helps discriminate 
between favorable and adverse outcomes in our cohort of patients. 
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This result is consistent with previous findings reported by Soummer 
et al28 Thus, a score based on sonographic (ie, anatomical), func-
tional, and clinical clues may be the most reliable means to provide a 
quick evaluation of the patient from complementary points of view.
COWS is based on LUS, P/F ratio, dyspnea, number of disease, 
and days from symptoms. For this reason, it acts as both a quick bed-
side tool and a screening test with a high negative predictive value. 
These two features suggest its usefulness in the context of the rapid 
evaluation of multiple patients presenting to the ED to avoid inap-
propriate resource use on low-risk patients saving costly resources 
for a minor number of high-risk patients. To this extent, the use of 
COWS may help increase appropriateness in the deployment of ra-
diological resources, ventilatory equipment, and ICU admissions. 
Finally, one of the advantages of COWS compared to the GRAM 
score may also be its quick repeatability over time.
In the likely event of a second-wave massive inflow of patients 
overwhelming hospital resources, patients may be listed according 
to the calculated predicted risk, in order to help the decision on 
resource allocation. In particular, stratifying patients by means of 
COWS may help set the appropriate monitoring level and aid in the 
difficult process of applying reverse triage criteria for ICU access in 
extreme conditions.29
In the context of a long-lasting epidemic, where a model of hub-
and-spoke COVID-19 hospitals might be used, COWS may speed up 
the selection of the low-risk patients who may be safely transferred 
to spokes, keeping high-risk patients in the hub center.
This study has several limitations. Firstly, it is a retrospective sin-
gle-center study and the sample size was relatively limited, as com-
plete data were available for 143 patients. Moreover, even if the 
assessment of internal validity suggests potential usefulness of our 
newly developed score in clinical practice, however, external valida-
tion is needed to enhance the generalizability of our findings. A bigger 
multicenter, prospective research effort would also be advisable for 
a greater sample size collection. Secondly, despite COWS' ability to 
identify low-risk patients, recognition of high-risk patients remains 
suboptimal, and further adjustment should be applied. Thirdly, we 
used GRAM’ variable selection to build our model, instead of start-
ing from all the possible variables collected in our patients. However, 
this approach is reasonable as the selected variables were variables 
with plausible clinical relation with the outcome. Fourthly, the P/F 
may have been calculated on very different FiO2 and with different 
levels of PEEP (from ZEEP to even 10 cmH2O). Finally, we tried to as-
sess whether a thoracic CT scan might be combined with COWS as a 
second level examination in selected patients to improve the overall 
accuracy, but we did not find promising results for this purpose, possi-
bly due to the limited number of observations. Of note, the cross-sec-
tional area of fat tissue at T7-T8 vertebral height, assessed in Colombi 
et al,11 was not measured in our study due to CT software limitations.
5  | CONCLUSION
COVID-19 pandemic has severely challenged hospitals' capacity in 
providing intensive levels of care. After validating the COVID-GRAM 
score in our population, we identified a simplified version of the 
score, by integrating LUS findings, functional, and selected clinical 
data. The COWS is bedside, quick, and easy to calculate. Its result is 
able to accurately identify patients who are unlikely to deteriorate or 
need ICU admission, sparing resources for the minority of COVID-19 
patients with a high-risk of developing critical illness.
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